According to the National Cancer Institute’s SEER (Surveillance, Epidemiology, and End Results) database, the 5-year case fatality rate for patients diagnosed with acute myeloid leukemia (AML) is 70.5%, meaning that only 29.5% of patients survive longer than 5 years. Survival rates are highly dependent on the age of the patient, the biology of the disease, and other factors. For people 20 years of age and older, the five-year AML case-fatality rate is 74%, but for people under 20 years of age, the AML case-fatality rate drops to 32%. AML is serious for people with the disease, especially those over the age of 60, but it is treatable and potentially curable in younger people and those with certain subtypes of the disease. If AML is diagnosed, it should be treated in a hospital under the supervision of a physician.